Direktorat Registrasi ObatValid

KANDISTATIN

BPOM Number: DKL9016105033A1
Approved: 16 May 2025
Expiry: 9 May 2030
Form: Suspension

About This Registration

KANDISTATIN is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL9016105033A1. Its current registration status is Valid, with the licence valid until 9 May 2030. The product is registered to METISKA FARMA - INDONESIA. BPOM first approved this registration in May 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 BOTOL @ 12 ML
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

METISKA FARMA - INDONESIA
KODYA JAKARTA SELATAN
NPWP: 010008910062000
owner
View profile →

Manufacturing Sites

METISKA FARMA - INDONESIA
KODYA JAKARTA SELATAN
primary
View profile →

Ingredients (1)

NYSTATIN

Market Intelligence

Owner Portfolio: METISKA FARMA - INDONESIA holds 34 BPOM registrations
Manufacturer Scale: METISKA FARMA - INDONESIA produces 34 registered products
Registration Age: Registered for 1 year, 4 months

Is this your product?